PRESS RELEASE published on 07/05/2023 at 17:41, 1 year 4 months ago EQS-Adhoc: CTS Eventim AG & Co. KGaA: Consent to the proposed settlement in the car toll dispute arbitration proceedings
PRESS RELEASE published on 05/25/2023 at 09:00, 1 year 5 months ago CTS EVENTIM gives the go-ahead for Italy’s largest and most innovative multipurpose arena – TREVI commissioned with first construction phase
PRESS RELEASE published on 05/18/2023 at 10:00, 1 year 6 months ago CTS EVENTIM makes a strong start to 2023, generating substantial growth in revenue and normalised EBITDA
PRESS RELEASE published on 04/26/2023 at 11:00, 1 year 6 months ago CTS EVENTIM new ticketing partner of Dresden’s Semper Opera House
PRESS RELEASE published on 04/19/2023 at 11:40, 1 year 7 months ago CTS EVENTIM founds EDGE, a paid media agency for the entertainment market
PRESS RELEASE published on 04/05/2023 at 11:00, 1 year 7 months ago CTS EVENTIM appoints Karsten Elbrecht as Chief Commercial Officer Ticketing Germany
PRESS RELEASE published on 03/23/2023 at 15:00, 1 year 7 months ago EQS-Adhoc: CTS EVENTIM - Executive Board and Supervisory Board propose payment of a dividend
PRESS RELEASE published on 03/23/2023 at 07:30, 1 year 7 months ago CTS EVENTIM continues to grow and posts record results for 2022
PRESS RELEASE published on 03/21/2023 at 09:30, 1 year 8 months ago CTS EVENTIM, MAMMOTH, INC. and AG ENTERTAINMENT TOURING to partner for major U.S. and global tours
PRESS RELEASE published on 02/16/2023 at 07:31, 1 year 9 months ago EQS-Adhoc: CTS Eventim: Record-breaking performance in 2022 with substantial revenue and profit growth
Published on 11/21/2024 at 13:30, 25 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 25 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 55 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 55 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 55 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 20 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 40 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 57 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 35 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 10 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 10 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
